Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16)

The recurring chromosome translocation t(11;16)(q23;p13) is detected in leukemia patients, virtually all of whom have received previous chemotherapy with topoisomerase (topo) II inhibitors. In the t(11;16), 3′ CBP, on 16p13, is fused to 5′ MLL, on 11q23, resulting in an MLL–CBP fusion gene that plays an important role in leukemogenesis. In this study, we cloned genomic breakpoints of the MLL and CBP genes in the t(11;16) in the SN‐1 cell line and in five patients with therapy‐related leukemia, all of whom had received topo II inhibitors for previous tumors. In all patients except one, both the genomic MLL–CBP and the reciprocal fusions were cloned. Genomic breakpoints in MLL occurred in the 8.3‐kb breakpoint cluster region in all patients, whereas the breakpoints in CBP clustered in an 8.2‐kb region of intron 3 in four patients. Genomic breakpoints in MLL occurred in intron 11 near the topo II cleavage site in the SN‐1 cell line and in one patient, and they were close to LINE repetitive sequences in two other patients. In the remaining two patients, genomic breakpoints were in intron 9 in Alu repeats. Genomic breakpoints in CBP occurred in and around Alu repeats in one and two patients, respectively. In two patients, the breaks were near LINE repetitive sequences, suggesting that repetitive DNA sequences may play a role. No specific recombination motifs were identified at or near the breakpoint junctions. No topo II cleavage sites were detected in introns 2 and 3 of CBP. However, there were deletions and duplications at the breakpoints in both MLL and CBP and microhomologies or nontemplated nucleotides at most of the genomic fusion junctions, suggesting that a nonhomologous end‐joining repair mechanism was involved in the t(11;16). © 2004 Wiley‐Liss, Inc.

[1]  C. Rudin,et al.  Human Alu element retrotransposition induced by genotoxic stress , 2003, Nature Genetics.

[2]  A. Borkhardt,et al.  Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: Almost identical MLL breakpoints in therapy‐related AML after treatment without etoposides , 2003, Genes, chromosomes & cancer.

[3]  M. Odero,et al.  t(10;16)(q22;p13) and MORF‐CREBBP fusion is a recurrent event in acute myeloid leukemia , 2003, Genes, chromosomes & cancer.

[4]  M. Segal,et al.  Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia , 2003, Genes, chromosomes & cancer.

[5]  B. Johansson,et al.  Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage‐repair mechanism in the origin of the t(8;16)(p11;p13) , 2003, Genes, chromosomes & cancer.

[6]  J. Squire,et al.  The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors , 2002, Genes, chromosomes & cancer.

[7]  O. Haas,et al.  Felix Mitelman: Database of chromosome aberrations in cancer , 2002, Human Genetics.

[8]  J. Rowley,et al.  Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Segal,et al.  Molecular characterization of genomic AML1-ETO fusions in childhood leukemia , 2001, Leukemia.

[10]  O. Haas,et al.  Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL , 2001, Oncogene.

[11]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[12]  B. Johansson,et al.  Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). , 2001, Human molecular genetics.

[13]  M. Greaves,et al.  Microclustering of TEL‐AML1 translocation breakpoints in childhood acute lymphoblastic leukemia , 2000, Genes, chromosomes & cancer.

[14]  Changchun Du,et al.  Chromatin‐related properties of CBP fused to MLL generate a myelodysplastic‐like syndrome that evolves into myeloid leukemia , 2000, The EMBO journal.

[15]  B. Roe,et al.  DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. , 2000, Human molecular genetics.

[16]  T. Taki,et al.  SN-1, a novel leukemic cell line with t(11;16)(q23;p13): myeloid characteristics and resistance to retinoids and vitamin D3. , 2000, Cancer research.

[17]  A. Borkhardt,et al.  A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells , 1999, Oncogene.

[18]  M. Greaves,et al.  Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. , 1999, Cancer research.

[19]  R. Marschalek,et al.  Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation , 1998, Oncogene.

[20]  F. Behm,et al.  Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints , 1998, Leukemia.

[21]  J. Rowley,et al.  An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. , 1998, Blood.

[22]  M. Caligiuri,et al.  The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Y. Hayashi,et al.  Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). , 1997, Blood.

[24]  B. Roe,et al.  Identification of complex genomic breakpoint junctions in the t(9;11) MLL‐AF9 fusion gene in acute leukemia , 1997 .

[25]  Y. Kaneko,et al.  Novel MLL‐CBP fusion transcript in therapy‐related chronic myelomonocytic leukemia with a t(11;16) (q23;p13) chromosome translocation , 1997, Genes, chromosomes & cancer.

[26]  D. Housman,et al.  MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Behm,et al.  All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. , 1997, Blood.

[28]  M. Stanulla,et al.  DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis , 1997, Molecular and cellular biology.

[29]  Y. Hayashi,et al.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. , 1997, Blood.

[30]  C. Disteche,et al.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein , 1996, Nature Genetics.

[31]  R. Marschalek,et al.  Exon/intron structure of the human ALL‐1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias , 1996, British journal of haematology.

[32]  M. Stanulla,et al.  Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. , 1996, Blood.

[33]  N. Zeleznik-Le,et al.  Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. , 1996, Blood.

[34]  Jerzy Jurka,et al.  Censor - a Program for Identification and Elimination of Repetitive Elements From DNA Sequences , 1996, Computers and Chemistry.

[35]  T. Haferlach,et al.  Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies , 1996, British journal of haematology.

[36]  D. Head,et al.  Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). , 1995, Leukemia.

[37]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[38]  C. Felix,et al.  ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. , 1995, Blood.

[39]  M. Caligiuri,et al.  ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. , 1994, Cancer research.

[40]  A. Zelenetz,et al.  BCL2 oncogene translocation is mediated by a chi-like consensus , 1992, The Journal of experimental medicine.

[41]  R. Baer,et al.  The chromosome translocation (11;14)(p13;q11) associated with T cell acute leukemia. Asymmetric diversification of the translocational junctions , 1990, The Journal of experimental medicine.

[42]  R. Berger,et al.  Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation. , 1989, Nucleic acids research.

[43]  U. K. Laemmli,et al.  Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold , 1984, Cell.

[44]  Y. Hayashi,et al.  MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. , 2000, Genes, chromosomes & cancer.

[45]  P. D. de Jong,et al.  ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. , 1999, Blood.

[46]  A. Omori,et al.  A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations , 1995, Nature Genetics.